104 related articles for article (PubMed ID: 38837338)
1. The impact of the European Society of Cardiology guidelines and whole exome sequencing on genetic testing in hereditary cardiac diseases.
Mio C; Zucco J; Fabbro D; Bregant E; Baldan F; Allegri L; D'Elia AV; Collini V; Imazio M; Damante G; Faletra F
Clin Genet; 2024 Jun; ():. PubMed ID: 38837338
[TBL] [Abstract][Full Text] [Related]
2. Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling.
Mørup SB; Nazaryan-Petersen L; Gabrielaite M; Reekie J; Marquart HV; Hartling HJ; Marvig RL; Katzenstein TL; Masmas TN; Lundgren J; Murray DD; Helleberg M; Borgwardt L
Front Immunol; 2022; 13():906328. PubMed ID: 35874679
[TBL] [Abstract][Full Text] [Related]
3. [Comparison study of whole exome sequencing and targeted panel sequencing in molecular diagnosis of inherited retinal dystrophies].
Liu XZ; Li YY; Yang LP
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):836-844. PubMed ID: 33047716
[TBL] [Abstract][Full Text] [Related]
4. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
[TBL] [Abstract][Full Text] [Related]
5. Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care context.
van Slobbe M; van Haeringen A; Vissers LELM; Bijlsma EK; Rutten JW; Suerink M; Nibbeling EAR; Ruivenkamp CAL; Koene S
Eur J Pediatr; 2024 Jan; 183(1):345-355. PubMed ID: 37889289
[TBL] [Abstract][Full Text] [Related]
6. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study.
Lord J; McMullan DJ; Eberhardt RY; Rinck G; Hamilton SJ; Quinlan-Jones E; Prigmore E; Keelagher R; Best SK; Carey GK; Mellis R; Robart S; Berry IR; Chandler KE; Cilliers D; Cresswell L; Edwards SL; Gardiner C; Henderson A; Holden ST; Homfray T; Lester T; Lewis RA; Newbury-Ecob R; Prescott K; Quarrell OW; Ramsden SC; Roberts E; Tapon D; Tooley MJ; Vasudevan PC; Weber AP; Wellesley DG; Westwood P; White H; Parker M; Williams D; Jenkins L; Scott RH; Kilby MD; Chitty LS; Hurles ME; Maher ER;
Lancet; 2019 Feb; 393(10173):747-757. PubMed ID: 30712880
[TBL] [Abstract][Full Text] [Related]
7. Targeted gene panel provides advantages over whole-exome sequencing for diagnosing obesity and diabetes mellitus.
Yu H; Yu H; Zhang R; Peng D; Yan D; Gu Y; Bao Y; Jia W; Zhang H; Hu C
J Mol Cell Biol; 2023 Nov; 15(6):. PubMed ID: 37327085
[TBL] [Abstract][Full Text] [Related]
8. Fundoscopy-directed genetic testing to re-evaluate negative whole exome sequencing results.
Cho A; Lima de Carvalho JR; Tanaka AJ; Jauregui R; Levi SR; Bassuk AG; Mahajan VB; Tsang SH
Orphanet J Rare Dis; 2020 Jan; 15(1):32. PubMed ID: 32000842
[TBL] [Abstract][Full Text] [Related]
9. Validation of a targeted gene panel sequencing for the diagnosis of hereditary chronic liver diseases.
Ronzoni L; Marini I; Passignani G; Malvestiti F; Marchelli D; Bianco C; Pelusi S; Prati D; Valenti L
Front Genet; 2023; 14():1137016. PubMed ID: 37388930
[No Abstract] [Full Text] [Related]
10. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency.
Platt CD; Zaman F; Bainter W; Stafstrom K; Almutairi A; Reigle M; Weeks S; Geha RS; Chou J;
J Allergy Clin Immunol; 2021 Feb; 147(2):723-726. PubMed ID: 32888943
[TBL] [Abstract][Full Text] [Related]
11. Combining Panel-Based Next-Generation Sequencing and Exome Sequencing for Genetic Liver Diseases.
Chen CB; Hsu JS; Chen PL; Wu JF; Li HY; Liou BY; Chang MH; Ni YH; Hwu WL; Chien YH; Chou YY; Yang YJ; Lee NC; Chen HL
J Pediatr; 2023 Jul; 258():113408. PubMed ID: 37019333
[TBL] [Abstract][Full Text] [Related]
12. Universal Exome Sequencing in Critically Ill Adults: A Diagnostic Yield of 25% and Race-Based Disparities in Access to Genetic Testing.
Gold J; Kripke CM; ; ; Drivas TG
medRxiv; 2024 Apr; ():. PubMed ID: 38559092
[TBL] [Abstract][Full Text] [Related]
13. Comparison of first-tier whole-exome sequencing with a multi-step traditional approach for diagnosing paediatric outpatients: An Italian prospective study.
Rosina E; Pezzani L; Apuril E; Pezzoli L; Marchetti D; Bellini M; Lucca C; Meossi C; Massimello M; Mariani M; Scatigno A; Cattaneo E; Colombo L; Maitz S; Cereda A; Milani D; Spaccini L; Bedeschi MF; Selicorni A; Iascone M
Mol Genet Genomic Med; 2024 Jan; 12(1):e2316. PubMed ID: 38041506
[TBL] [Abstract][Full Text] [Related]
14. Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases.
Pena LDM; Jiang YH; Schoch K; Spillmann RC; Walley N; Stong N; Rapisardo Horn S; Sullivan JA; McConkie-Rosell A; Kansagra S; Smith EC; El-Dairi M; Bellet J; Keels MA; Jasien J; Kranz PG; Noel R; Nagaraj SK; Lark RK; Wechsler DSG; Del Gaudio D; Leung ML; Hendon LG; Parker CC; Jones KL; ; Goldstein DB; Shashi V
Genet Med; 2018 Apr; 20(4):464-469. PubMed ID: 28914269
[TBL] [Abstract][Full Text] [Related]
15. Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy.
Harris E; Topf A; Barresi R; Hudson J; Powell H; Tellez J; Hicks D; Porter A; Bertoli M; Evangelista T; Marini-Betollo C; Magnússon Ó; Lek M; MacArthur D; Bushby K; Lochmüller H; Straub V
Orphanet J Rare Dis; 2017 Sep; 12(1):151. PubMed ID: 28877744
[TBL] [Abstract][Full Text] [Related]
16. Impact of variation in practice in the prenatal reporting of variants of uncertain significance by commercial laboratories: Need for greater adherence to published guidelines.
Cornthwaite M; Turner K; Armstrong L; Boerkoel CF; Chang C; Lehman A; Nikkel SM; Patel MS; Van Allen M; Langlois S
Prenat Diagn; 2022 Nov; 42(12):1514-1524. PubMed ID: 36068917
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Whole-Exome Sequencing for the Identification of Causal Mutations in Patients with Suspected Inherited Ocular Diseases.
Ordoñez-Labastida V; Montes-Almanza L; García-Martínez F; Zenteno JC
Rev Invest Clin; 2022; 74(4):219-226. PubMed ID: 36087940
[TBL] [Abstract][Full Text] [Related]
18. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
[TBL] [Abstract][Full Text] [Related]
19. Semiconductor Whole Exome Sequencing for the Identification of Genetic Variants in Colombian Patients Clinically Diagnosed with Long QT Syndrome.
Burgos M; Arenas A; Cabrera R
Mol Diagn Ther; 2016 Aug; 20(4):353-62. PubMed ID: 27251404
[TBL] [Abstract][Full Text] [Related]
20. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
